This Article  • References  • Full text PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Michael J. Zigmond, PhD; Ann L. Acheson, PhD; Michal K. Stachowiak, PhD; Edward M. Strickerm, PhD

Arch Neurol. 1984;41(8):856-861.

Abstract
• Parkinson's disease usually involves a lengthy preclinical period during which few neurological symptoms are observed despite extensive damage to the dopaminergic nigrostriatal bundle. Injury to this projection in the rat also fails to produce major neurological dysfunctions. In our studies, damage to the nigrostriatal bundle of the rat, resulting in the loss of up to 95% of the dopaminergic terminals in striatum, was accompanied by apparent increases in the synthesis and release of dopamine (DA) from those dopaminergic terminals that remained. More specifically, both the activity of the rate-limiting biosynthetic enzyme, tyrosine hydroxylase, and the content of the principal DA metabolite, dihydroxyphenylacetic acid, were increased in striatum relative to DA levels. The increases were exponentially related to DA loss.

Author Affiliations
From the Departments of Biological Sciences, Psychology, and Psychiatry, University of Pittsburgh. Dr Acheson is now at the Max-Plank-Institut for Psychiatry, Munich.

Footnotes
Accepted for publication Oct 13, 1983.

Reprint requests to 573 Crawford Hall, Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260 (Dr Zigmond).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mechanisms compensating for dopamine loss in early Parkinson disease
Brotchie and Fitzer-Attas
Neurology 2009;72:S32-S38.
ABSTRACT | FULL TEXT  

A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery
Mounayar et al.
Brain 2007;130:2898-2914.
ABSTRACT | FULL TEXT  

Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.
Quik et al.
J. Neurosci. 2006;26:4681-4689.
ABSTRACT | FULL TEXT  

Dopamine release during sequential finger movements in health and Parkinson's disease: a PET study
Goerendt et al.
Brain 2003;126:312-325.
ABSTRACT | FULL TEXT  

Book Review: Forced Limb-Use and Recovery following Brain Injury
Tillerson and Miller
Neuroscientist 2002;8:574-585.
ABSTRACT  

Forced Nonuse in Unilateral Parkinsonian Rats Exacerbates Injury
Tillerson et al.
J. Neurosci. 2002;22:6790-6799.
ABSTRACT | FULL TEXT  

The Role of Dopamine Receptors in Regulating the Size of Axonal Arbors
Parish et al.
J. Neurosci. 2001;21:5147-5157.
ABSTRACT | FULL TEXT  

Age-Related Changes in the Capacity, Rate, and Modulation of Dopamine Uptake within the Striatum and Nucleus Accumbens of Fischer 344 Rats: An In Vivo Electrochemical Study
Hebert and Gerhardt
J. Pharmacol. Exp. Ther. 1999;288:879-887.
ABSTRACT | FULL TEXT  

Compensatory Mechanisms in Degenerative Neurologic Diseases: Insights From Parkinsonism
Calne and Zigmond
Arch Neurol 1991;48:361-363.
ABSTRACT